These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


299 related items for PubMed ID: 28283184

  • 1. Angiotensin-(1-7) regulates angiotensin II-induced matrix metalloproteinase-8 in vascular smooth muscle cells.
    Zhang F, Li S, Song J, Liu J, Cui Y, Chen H.
    Atherosclerosis; 2017 Jun; 261():90-98. PubMed ID: 28283184
    [Abstract] [Full Text] [Related]

  • 2. Liraglutide, a GLP-1 receptor agonist, inhibits vascular smooth muscle cell proliferation by enhancing AMP-activated protein kinase and cell cycle regulation, and delays atherosclerosis in ApoE deficient mice.
    Jojima T, Uchida K, Akimoto K, Tomotsune T, Yanagi K, Iijima T, Suzuki K, Kasai K, Aso Y.
    Atherosclerosis; 2017 Jun; 261():44-51. PubMed ID: 28445811
    [Abstract] [Full Text] [Related]

  • 3. Angiotensin-(1-7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells.
    Yang JM, Dong M, Meng X, Zhao YX, Yang XY, Liu XL, Hao PP, Li JJ, Wang XP, Zhang K, Gao F, Zhao XQ, Zhang MX, Zhang Y, Zhang C.
    Arterioscler Thromb Vasc Biol; 2013 Aug; 33(8):1978-85. PubMed ID: 23723368
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice.
    Nemoto W, Ogata Y, Nakagawasai O, Yaoita F, Tadano T, Tan-No K.
    Eur J Pain; 2014 Nov; 18(10):1471-9. PubMed ID: 24733750
    [Abstract] [Full Text] [Related]

  • 5. Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway.
    Bihl JC, Zhang C, Zhao Y, Xiao X, Ma X, Chen Y, Chen S, Zhao B, Chen Y.
    Vascul Pharmacol; 2015 Oct; 73():115-123. PubMed ID: 26264508
    [Abstract] [Full Text] [Related]

  • 6. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K, Shirai R, Hontani M, Shinooka R, Hasegawa A, Kichise T, Yamashita T, Yoshizawa H, Watanabe R, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T.
    J Am Heart Assoc; 2017 Apr 14; 6(4):. PubMed ID: 28411243
    [Abstract] [Full Text] [Related]

  • 7. Genistein inhibits Ang II-induced CRP and MMP-9 generations via the ER-p38/ERK1/2-PPARγ-NF-κB signaling pathway in rat vascular smooth muscle cells.
    Xu L, Liu JT, Li K, Wang SY, Xu S.
    Life Sci; 2019 Jan 01; 216():140-146. PubMed ID: 30452971
    [Abstract] [Full Text] [Related]

  • 8. Alamandine attenuates angiotensin II-induced vascular fibrosis via inhibiting p38 MAPK pathway.
    Yang C, Wu X, Shen Y, Liu C, Kong X, Li P.
    Eur J Pharmacol; 2020 Sep 15; 883():173384. PubMed ID: 32707188
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-(1-7) Attenuates Angiotensin II-Induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-κB Pathways in HUVECs.
    Liang B, Wang X, Zhang N, Yang H, Bai R, Liu M, Bian Y, Xiao C, Yang Z.
    Cell Physiol Biochem; 2015 Sep 15; 35(6):2472-82. PubMed ID: 25967876
    [Abstract] [Full Text] [Related]

  • 10. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M, Ikutomi M, Morita T, Minami Y, Nakajima T, Hirata Y, Nagai R, Sata M.
    Cardiovasc Res; 2014 Feb 01; 101(2):236-46. PubMed ID: 24193738
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-(1-7) modulates renal vascular resistance through inhibition of p38 mitogen-activated protein kinase in apolipoprotein E-deficient mice.
    Potthoff SA, Fähling M, Clasen T, Mende S, Ishak B, Suvorava T, Stamer S, Thieme M, Sivritas SH, Kojda G, Patzak A, Rump LC, Stegbauer J.
    Hypertension; 2014 Feb 01; 63(2):265-72. PubMed ID: 24191281
    [Abstract] [Full Text] [Related]

  • 12. AVE0991, a nonpeptide angiotensin-(1-7) mimic, inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E knockout mice.
    Ma H, Wang YL, Hei NH, Li JL, Cao XR, Dong B, Yan WJ.
    J Mol Med (Berl); 2020 Apr 01; 98(4):541-551. PubMed ID: 32060588
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-hypersensitive effect of angiotensin (1-7) on streptozotocin-induced diabetic neuropathic pain in mice.
    Ogata Y, Nemoto W, Yamagata R, Nakagawasai O, Shimoyama S, Furukawa T, Ueno S, Tan-No K.
    Eur J Pain; 2019 Apr 01; 23(4):739-749. PubMed ID: 30421564
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Membrane-Tethered Metalloproteinase Expressed by Vascular Smooth Muscle Cells Limits the Progression of Proliferative Atherosclerotic Lesions.
    Barnes RH, Akama T, Öhman MK, Woo MS, Bahr J, Weiss SJ, Eitzman DT, Chun TH.
    J Am Heart Assoc; 2017 Jul 22; 6(7):. PubMed ID: 28735290
    [Abstract] [Full Text] [Related]

  • 17. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner.
    Browatzki M, Larsen D, Pfeiffer CA, Gehrke SG, Schmidt J, Kranzhofer A, Katus HA, Kranzhofer R.
    J Vasc Res; 2005 Jul 22; 42(5):415-23. PubMed ID: 16103692
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II Induces an Increase in Matrix Metalloproteinase 2 Expression in Aortic Smooth Muscle Cells of Ascending Thoracic Aortic Aneurysms Through JNK, ERK1/2, and p38 MAPK Activation.
    Wang C, Chang Q, Sun X, Qian X, Liu P, Pei H, Guo X, Liu W.
    J Cardiovasc Pharmacol; 2015 Sep 22; 66(3):285-93. PubMed ID: 25955575
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M, Chen R, Li Z, Shiuchi T, Suzuki J, Ide A, Tsuda M, Okumura M, Min LJ, Mogi M, Horiuchi M.
    Circulation; 2005 Sep 13; 112(11):1636-43. PubMed ID: 16145000
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.